Your browser doesn't support javascript.
loading
20 years of rituximab treatment: what have we learnt?
Renner, Christoph.
Affiliation
  • Renner C; OnkoZentrum Hirslanden, Zürich, Switzerland.
Future Oncol ; 15(36): 4119-4121, 2019 Dec.
Article in En | MEDLINE | ID: mdl-31718346
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Molecular Targeted Therapy / Rituximab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Future Oncol Year: 2019 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Molecular Targeted Therapy / Rituximab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Future Oncol Year: 2019 Document type: Article Affiliation country: